| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/13/2002 | EP1178804A2 Use of topical azathioprine to treat inflammatory bowel disorders |
| 02/13/2002 | EP1178799A1 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 02/13/2002 | EP1178798A1 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate) |
| 02/13/2002 | EP1178793A2 Stable solid pharmaceutical compositions containing enalapril maleate |
| 02/13/2002 | EP1178787A1 Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof |
| 02/13/2002 | EP1178786A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 02/13/2002 | EP1178783A1 Device and method for increasing the transdermal permeation of medicaments |
| 02/13/2002 | EP1178782A2 Transdermal therapeutic system (tts) containing tolterodine |
| 02/13/2002 | EP1178781A1 Multilayer pharmaceutical product for release in the colon |
| 02/13/2002 | EP1178780A1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| 02/13/2002 | EP1178779A1 Ophthalmic insert and method for sustained release of medication to the eye |
| 02/13/2002 | EP1178778A2 Granules containing a plant substance and method for producing the same |
| 02/13/2002 | EP1178777A2 Form of administration for applying in body orifices |
| 02/13/2002 | EP1178737A1 Rapidly disintegrating flavor wafer for flavor enrichment |
| 02/13/2002 | EP0959834B1 Method for producing transdermal patches (tts) |
| 02/13/2002 | EP0910345B1 Biconvex rapidly disintegrating dosage forms |
| 02/13/2002 | EP0865289B1 Arctium majus compositions |
| 02/13/2002 | EP0847273B1 Improved pharmaceutical ion exchange resin composition |
| 02/13/2002 | EP0814781B1 Long-shelf-life medicaments |
| 02/13/2002 | EP0727997B1 Pharmaceutical emulsion |
| 02/13/2002 | CN2476278Y Health-care and treatment structure |
| 02/13/2002 | CN1335787A Apparatus and process for preparing crystalline particles |
| 02/13/2002 | CN1335772A Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males |
| 02/13/2002 | CN1335769A Controlled release formulation of divalproex sodium |
| 02/13/2002 | CN1335768A Multiparticulate modified release composition |
| 02/13/2002 | CN1335767A Sustained release matrix systems for highly soluble drugs |
| 02/13/2002 | CN1335766A A process for the preparation of suspensions of drug particles for inhalation delivery |
| 02/13/2002 | CN1335765A Polyol/oil suspensions for the sustained release of proteins |
| 02/13/2002 | CN1335764A Substrate composition and method of use for sequestration of skin irritants |
| 02/13/2002 | CN1335182A Insulin spray for oral cavity and its prepn process |
| 02/13/2002 | CN1335160A Burns treating ointment with functions of removing necrosis and promoting granulation |
| 02/13/2002 | CN1335158A Apoplexy-treating physique strengthening capsule |
| 02/13/2002 | CN1335154A Headache treating capsule |
| 02/13/2002 | CN1335152A Plaster for treating osteomyelitis and trauma |
| 02/13/2002 | CN1335145A External-use plaster for softening dry feces and dissipating mass |
| 02/13/2002 | CN1335144A Chinese medicine plaster for treating mastoproliferation and its prepn |
| 02/13/2002 | CN1335136A Oxygen-enriched NaCl injecta and its production process |
| 02/13/2002 | CN1335133A Composition and method for preventing and curing breast cancer |
| 02/13/2002 | CN1335131A Local administration preparation |
| 02/13/2002 | CN1335127A Probucol clathrate capsule and its prepn process |
| 02/13/2002 | CN1335126A Medical solid self-emulsifying composition for ensuring biological active combined material continuous transfer and its producing process |
| 02/13/2002 | CN1079029C Medical capsule for treating bone rheumatism and its preparing process |
| 02/13/2002 | CN1079028C Method for preparing traditional Chinese medicine for lithangiuria and biliary tract calculus |
| 02/12/2002 | US6346648 Polycarboxy alcohol amine as amphoteric suractants for shampoo and hair conditioners |
| 02/12/2002 | US6346611 High affinity TGfβ nucleic acid ligands and inhibitors |
| 02/12/2002 | US6346548 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 02/12/2002 | US6346537 Medicinal composition |
| 02/12/2002 | US6346528 Side effect reduction compared to olanzapine; capsules or tablets; psychological, gastrointestinal and bipolar disorders; anxiolytic agents, antidepressants |
| 02/12/2002 | US6346523 Controlling temperature and pressure of solution of budesonide in solvent and supercritical fluid so that dispersion and extraction occur concurrently; crystalline, fineness; respiratory system disorders |
| 02/12/2002 | US6346511 Pharmaceutical composition comprising cyclosporin |
| 02/12/2002 | US6346279 Antiseptics with phosphorous acid, anionic surfactants of alkylbenzenesulfonic acids and alkali or ammonium salts |
| 02/12/2002 | US6346274 Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof |
| 02/12/2002 | US6346273 Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles |
| 02/12/2002 | US6346272 Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
| 02/12/2002 | US6346271 Treatment of skin disorders using polymer sodium hyaluronate dermatitis. |
| 02/12/2002 | US6346270 Phenytoin therapy |
| 02/12/2002 | US6346269 Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby |
| 02/12/2002 | US6346268 Tablet for drug release |
| 02/12/2002 | US6346267 Composition and method for treatment of symptoms associated with insufficient estrogen production |
| 02/12/2002 | US6346263 Particles and matrices of graft polymers |
| 02/12/2002 | US6346242 Compounds and compositions for delivering active agents |
| 02/12/2002 | US6346233 Composition for treating cancer via liposomal aerosol formulation containing taxol |
| 02/12/2002 | US6346232 Aerosol formulation of beclomethasone-17,21-dipropionate, fluoroalkane propellants and ethanol |
| 02/12/2002 | US6346231 Flavored gelatin capsule and method of manufacture |
| 02/12/2002 | US6346098 Methods and kits for locally administering an active agent to an interstitial space of a host |
| 02/12/2002 | CA2303685C Fluorocarbon aerosol medicaments |
| 02/12/2002 | CA2229185C Plaster structure for iontophoresis |
| 02/12/2002 | CA2207218C Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure |
| 02/12/2002 | CA2131547C Composition for oral preparations |
| 02/12/2002 | CA2125500C Composition of antineoplastic agents incorporated in micelles |
| 02/12/2002 | CA2073453C Methods of enhancing wound healing and tissue repair |
| 02/12/2002 | CA2041378C Granulated preparations and method of producing the same |
| 02/12/2002 | CA2037569C Controlled release formulation |
| 02/12/2002 | CA2031358C Method and apparatus for the aerosol administration of medication |
| 02/12/2002 | CA2017349C Rubbers swellable with water and aqueous solutions and the method for producing the same |
| 02/07/2002 | WO2002010361A1 α-ISOMALTOSYLGLUCOSACCHARIDE SYNTHASE, PROCESS FOR PRODUCING THE SAME AND USE THEREOF |
| 02/07/2002 | WO2002010242A1 Polyurethane film-forming dispersions in alcohol-water system |
| 02/07/2002 | WO2002010148A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | WO2002009864A1 Encapsulation of liquid template particles |
| 02/07/2002 | WO2002009787A1 Microparticulate biomaterial composition for medical use |
| 02/07/2002 | WO2002009767A2 Therapeutic polyanhydride compounds for drug delivery |
| 02/07/2002 | WO2002009765A1 Methods for treating burns on mammalian skin to reduce the risk of infection and to minimize fluid loss |
| 02/07/2002 | WO2002009764A1 Combination compositions |
| 02/07/2002 | WO2002009729A2 Treatment of hyperproliferative skin disorders and diseases |
| 02/07/2002 | WO2002009724A1 Pharmaceutical compositions containing tobramycin and xanthan gum |
| 02/07/2002 | WO2002009716A2 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | WO2002009710A2 Paroxetine tablets and capsules |
| 02/07/2002 | WO2002009709A1 Method for reducing or eliminating smoking |
| 02/07/2002 | WO2002009707A1 Fentanyl composition for nasal administration |
| 02/07/2002 | WO2002009704A2 Pharmaceutical composition for transdermal delivery of befloxatone |
| 02/07/2002 | WO2002009702A2 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 02/07/2002 | WO2002009695A1 Bimodal emulsions of taxanes and butyrate polyalcohol esters |
| 02/07/2002 | WO2002009693A1 Method and compositions for prevention and/or treatment of diabetes and glucose modulation |
| 02/07/2002 | WO2002009690A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 02/07/2002 | WO2002009679A2 Use of 13-cis retinoic acid for the treatment of emphysema |
| 02/07/2002 | WO2002009678A2 Charged phospholipid compositions and methods for their use |
| 02/07/2002 | WO2002009676A1 Adhesive dressings for the treatment and prophylaxis of scars |
| 02/07/2002 | WO2002009675A1 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release |
| 02/07/2002 | WO2002009674A2 Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds |
| 02/07/2002 | WO2002009673A1 Granules based on starch and lactose |